The page is the record's research on the issuer — no analyst, no rating, no view.

# BioNexus Gene Lab Corp (NASDAQ: BGLC) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is BioNexus Gene Lab Corp, listed on NASDAQ under ticker BGLC, with ISIN US0906283066 and LEI 549300COYSKRA3Z7E531. Its security type is Corporate, its segment is not on the record, its sector is 8071 Services-Medical Laboratories, and its jurisdiction is United States, Wyoming. Its listing status is listed, not halted.

## The disclosure read

The record holds 31 filings in the twelve months to 2026-11-08, across 20 filing days. The median gap between filing days is 15 days. The latest filing is dated 2026-10-22, 17 days before the record date, and is of type regulatory_filing. The NASDAQ median cadence gap is 6.0 days, the median filings count is 52, and the median latency is 5.0 days across 4359 issuers. The sector median cadence gap is 5.5 days, the median filings count is 79, and the median latency is 3 days across 29 issuers. By type, the window holds 3 agm_egm, 10 corporate_news, 11 directors_dealings, 3 regulatory_filing and 4 results filings.

## Auditor

The auditor of record is JP CENTURION & PARTNERS PLT, located in Kuala Lumpur, Malaysia. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- https://data.sec.gov/submissions/CIK0001737523.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/BGLC (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1737523/000147793226002218/bglc_10k.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/BGLC (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/BGLC · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
